Celestica (CLS) PT Lowered to $430 at Barclays
Tweet
Share
E-mailGet Alerts CLS Hot Sheet
Price: $344.40 +3.54%
Rating Summary:
19 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Rating Summary:
19 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Join SI Premium – FREE
Barclays analyst George Wang lowered the price target on Celestica (NYSE: CLS) to $430.00 (from $441.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Adeptus Biotechnologies Corp. (ADPT) PT Raised to $34 at BTIG
- Plains All American (PAA) PT Raised to $28 at UBS
- Shift4 Payments (FOUR) PT Lowered to $56 at StoneX as Iran War Impacts Revenues
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
